On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to EUROGIN 2018.
Lisbon continues to be an interesting destination for the EUROGIN congress, which takes place here for the second time, following the positive experience in 2011. Indeed, in the area of HPV-related diseases, the medical and scientific environment in Portugal are very productive and conducive to progress and renewal, based on active and dynamic research; with the support of motivated local medical and professional organizations.
The city offers an infrastructure which corresponds to the logistical requirements of this type of international conference.
Over the last decades, the EUROGIN congress has gained a sound reputation as one of the leading international meetings on human papillomavirus infection and related cancers. The key purpose of the event remains unchanged: offering a high-level scientific forum to encourage multidisciplinary interactions to build a bridge between research and clinical action. The members of the scientific committee cover the whole spectrum of expertise in the field of HPV induced infections and associated diseases. Thanks to this top-ranking committee our program offers up-to-date scientific information all HPV-related diseases.
The main focus of the EUROGIN 2018 congress concerns the perspective of eliminating HPV induced diseases. Universal immunization of the entire population is a tremendeous opportunity to reduce the burden of cervical ,ano-genital and oral cancer worldwide. Elimination of HPV related cancer is not an unrealistic perspective.
The program includes the presentation of preliminary results which underline the long-term protection of the HPV vaccine against invasive cervical cancer. These findings open also the perspective of efficient protection against other HPV-associated cancers.
Over four days the EUROGIN congress will offer a variety of learning opportunities from which attendees can choose: training courses, workshops, scientific sessions, clinical sessions, free communications and poster presentations.
In addition to the international program, the “Workshop Lusófono” in Portuguese language, with its program designed in collaboration with the major scientific societies, will offer a comprehensive overview of the latest findings in HPV-related diseases for delegates from Portuguese speaking countries. Precision-based cancer screening and prevention is now possible. New technology and risk algorithms allow us to increase the precision of screening and the sensitiviy of existing tools for early detection and immunization.
Applying recent advances in genomics, proteomics and immunogenetics enhances our understanding of the biology of premalignancy and allows to identify new targets for interception. It is time to benefit from the scientific revolution in our field and to implement the new technologies in the real world of screening, early detection and immunization.
These are some of the goals of the EUROGIN 2018 congress. Time for action is now. We look forward to welcoming you at an exciting congress in the beautiful city of Lisbon